Banner Witcoff

A Banner Witcoff team led by Brian Emfinger and Binal Patel represented Clear-Vu Lighting as petitioner in an inter partes review of a patent directed to using blue light to inactivate certain types of bacteria.

Enablement, indefiniteness, and privity are just a few of the topics that Banner Witcoff's Roshan Bhattarai and Josh Davenport covered in our latest installment of PTAB Highlights.

Banner Witcoff's Evi Christou summarizes the U.S. Supreme Court's recent ruling in a key trademark case.

In its annual "IP Stars" guide, Managing IP recognized Banner Witcoff for its patent prosecution, PTAB litigation and trademark practices. The guide also lists 17 firm attorneys as IP Stars.

Banner Witcoff's Liz Brodzinski was quoted in two recent articles examining a surge of applications seeking to trademark the slogans "Black Lives Matter" and "I Can't Breathe."

As a professional services sponsor of the Maryland Energy Innovation Accelerator, Banner Witcoff provided pro bono IP counseling to teams participating in the program designed to help commericialize clearn energy technologies.

We are experiencing a critical moment in our nation’s history following the senseless deaths of George Floyd, Breonna Taylor, Ahmaud Arbery, and others. These and other recent troubling events underscore a long history of violence against the Black community despite the great strides our nation has made to advance justice and equality. At Banner Witcoff,…

Banner Witcoff’s patent prosecution and litigation practices are recognized in the 2020 edition of the IAM Patent 1000: The World’s Leading Patent Professionals, along with nearly a dozen of our attorneys.

The PTAB’s handling of Federal Circuit remand, prosecution history with overlapping prior art, and level of skill in the art are just a few of the topics that Banner Witcoff's Jihan Joo and Eric Zelepugas covered in our latest installment of PTAB Highlights.

On June 16, 1980, the U.S. Supreme Court issued a landmark decision in Diamond v. Chakrabarty, holding for the first time ever that a living, genetically-altered microorganism constituted patentable subject matter.